Innoviva Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Innoviva Stock Summary

Innoviva competes with Protalix Biotherapeutics, PDS Biotechnology, Elevation Oncology, Day One, and Amylyx Pharmaceuticals. Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California. Innoviva operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

Innoviva Key Financial Ratios

Innoviva Key Balance Sheet Accounts

Innoviva Key Income Statement Accounts

Innoviva Key Cash Accounts

Innoviva Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Innoviva's current stock value. Our valuation model uses many indicators to compare Innoviva value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innoviva competition to find correlations between indicators driving Innoviva's intrinsic value. More Info.Innoviva is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers reporting about  0.94  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Innoviva is roughly  1.06 . At present, Innoviva's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innoviva's earnings, one of the primary drivers of an investment's value.

Innoviva Systematic Risk

Today, most investors in Innoviva Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Innoviva's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Innoviva growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Innoviva help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innoviva. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innoviva based on widely used predictive technical indicators. In general, we focus on analyzing Innoviva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innoviva's daily price indicators and compare them against related drivers.

When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.